🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
This study will be conducted in two stages. In the diphtheria, tetanus, per...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-16
Trial ID
NCT00228917
Treatments Being Tested
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
The purpose of this study is to conduct long-term surveillance for efficacy...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-18
Trial ID
NCT02207816
The purpose of this study is: To assess whether there are differences in a...
Status
Completed
Location
Health Protection Agency
Start Date
2008-02
Trial ID
NCT00625677
Treatments Being Tested
The study investigated safety profile and the antibody responses to an expe...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00771849
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The purpose of this booster vaccination study is to evaluate the persistenc...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00135564
Treatments Being Tested
This multicentre, parallel group, block randomised clinical trial aims to i...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2015-08
Trial ID
NCT02482636
The primary phase of this study is evaluating the safety of Hib-MenCY-TT va...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09
Trial ID
NCT00345579